Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130


Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.

Pincus T, Richardson B, Strand V, Bergman MJ.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-47-54. Epub 2014 Oct 30.


GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.

Castrejón I, Pincus T, Soubrier M, Lin YC, Rat AC, Combe B, Dougados M.

Rheumatology (Oxford). 2013 Oct;52(10):1890-7. doi: 10.1093/rheumatology/ket230. Epub 2013 Jul 17.


Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level.

Riazzoli J, Nilsson JÅ, Teleman A, Petersson IF, Rantapää-Dahlqvist S, Jacobsson LT, van Vollenhoven RF.

Rheumatology (Oxford). 2010 Nov;49(11):2098-103. doi: 10.1093/rheumatology/keq197. Epub 2010 Jul 8.


Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations.

Sokka T, Pincus T.

Rheum Dis Clin North Am. 2009 Nov;35(4):713-22, v-vi. doi: 10.1016/j.rdc.2009.10.004. Review.


Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.

Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-Sáez I, Unnebrink K, Kary S, Kupper H.

Arthritis Rheum. 2008 Jan 15;59(1):32-41. doi: 10.1002/art.23247.


Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.

Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T.

J Rheumatol. 2013 Apr;40(4):386-93. doi: 10.3899/jrheum.121059. Epub 2013 Feb 1.


American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M.

Ann Rheum Dis. 2011 Mar;70(3):404-13. doi: 10.1136/ard.2011.149765.


Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care.

Pincus T, Sokka T.

Best Pract Res Clin Rheumatol. 2003 Oct;17(5):753-81. Review.


Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis.

Barton JL, Criswell LA, Kaiser R, Chen YH, Schillinger D.

J Rheumatol. 2009 Dec;36(12):2635-41. doi: 10.3899/jrheum.090569. Epub 2009 Nov 16. Review.


Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.

Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, Géher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS, Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro Gda R, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T; QUEST-RA Group.

Arthritis Res Ther. 2009;11(1):R7. doi: 10.1186/ar2591. Epub 2009 Jan 14.

Supplemental Content

Support Center